Ignite Creation Date:
2024-05-06 @ 3:55 AM
Last Modification Date:
2024-10-26 @ 11:40 AM
Study NCT ID:
NCT02402660
Status:
RECRUITING
Last Update Posted:
2024-06-21
First Post:
2015-03-09
Brief Title:
Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease
Sponsor:
Alkeus Pharmaceuticals Inc
Organization:
Alkeus Pharmaceuticals Inc
Organization Data
Organization:
Alkeus Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
ALK001-P1002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Alkeus Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None